Variant report
Variant | esv1830089 |
---|---|
Chromosome Location | chr2:74010341-74036605 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:651)
- CpG islands (count:183)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr2:74025837-74026193 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr2:74031630-74031925 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr2:74026730-74027025 | GM12878 | blood: | n/a | n/a |
4 | BATF | chr2:74016935-74017230 | GM12878 | blood: | n/a | n/a |
5 | BATF | chr2:74022114-74022314 | GM12878 | blood: | n/a | n/a |
6 | BATF | chr2:74011334-74011570 | GM12878 | blood: | n/a | n/a |
7 | BATF | chr2:74011141-74011519 | GM12878 | blood: | n/a | n/a |
8 | BATF | chr2:74036598-74036799 | GM12878 | blood: | n/a | n/a |
9 | BATF | chr2:74035636-74036014 | GM12878 | blood: | n/a | n/a |
10 | BATF | chr2:74027012-74027212 | GM12878 | blood: | n/a | n/a |
11 | BATF | chr2:74030737-74031093 | GM12878 | blood: | n/a | n/a |
12 | BATF | chr2:74016042-74016398 | GM12878 | blood: | n/a | n/a |
13 | BATF | chr2:74012316-74012516 | GM12878 | blood: | n/a | n/a |
14 | BATF | chr2:74020939-74021295 | GM12878 | blood: | n/a | n/a |
15 | BATF | chr2:74021832-74022127 | GM12878 | blood: | n/a | n/a |
16 | BATF | chr2:74031912-74032112 | GM12878 | blood: | n/a | n/a |
17 | BATF | chr2:74017217-74017417 | GM12878 | blood: | n/a | n/a |
18 | BATF | chr2:74012103-74012308 | GM12878 | blood: | n/a | n/a |
19 | BCL11A | chr2:74016103-74016296 | GM12878 | blood: | n/a | n/a |
20 | BCL11A | chr2:74021083-74021430 | GM12878 | blood: | n/a | n/a |
21 | BCL11A | chr2:74011201-74011579 | GM12878 | blood: | n/a | n/a |
22 | BCL11A | chr2:74021000-74021193 | GM12878 | blood: | n/a | n/a |
23 | BCL11A | chr2:74019834-74020077 | GM12878 | blood: | n/a | n/a |
24 | BCL11A | chr2:74016186-74016533 | GM12878 | blood: | n/a | n/a |
25 | BCL11A | chr2:74030798-74030991 | GM12878 | blood: | n/a | n/a |
26 | BCL11A | chr2:74024732-74024975 | GM12878 | blood: | n/a | n/a |
27 | BCL11A | chr2:74014937-74015180 | GM12878 | blood: | n/a | n/a |
28 | BCL11A | chr2:74025898-74026091 | GM12878 | blood: | n/a | n/a |
29 | BCL11A | chr2:74012160-74012430 | GM12878 | blood: | n/a | n/a |
30 | BCL11A | chr2:74030881-74031228 | GM12878 | blood: | n/a | n/a |
31 | BCL11A | chr2:74025981-74026328 | GM12878 | blood: | n/a | n/a |
32 | BCL11A | chr2:74035780-74036074 | GM12878 | blood: | n/a | n/a |
33 | BHLHE40 | chr2:74024538-74024760 | HepG2 | liver: | n/a | n/a |
34 | BHLHE40 | chr2:74019640-74019862 | HepG2 | liver: | n/a | n/a |
35 | BHLHE40 | chr2:74029434-74029671 | HepG2 | liver: | n/a | n/a |
36 | BHLHE40 | chr2:74014743-74014965 | HepG2 | liver: | n/a | n/a |
37 | BHLHE40 | chr2:74034334-74034571 | HepG2 | liver: | n/a | n/a |
38 | CTCF | chr2:74036098-74036178 | GM10248 | blood: | n/a | n/a |
39 | EBF1 | chr2:74030685-74030964 | GM12878 | blood: | n/a | n/a |
40 | EBF1 | chr2:74011309-74011503 | GM12878 | blood: | n/a | n/a |
41 | EBF1 | chr2:74020887-74021166 | GM12878 | blood: | n/a | n/a |
42 | EBF1 | chr2:74020904-74021098 | GM12878 | blood: | n/a | n/a |
43 | EBF1 | chr2:74035601-74035795 | GM12878 | blood: | n/a | n/a |
44 | EBF1 | chr2:74015990-74016269 | GM12878 | blood: | n/a | n/a |
45 | EBF1 | chr2:74016007-74016201 | GM12878 | blood: | n/a | n/a |
46 | EBF1 | chr2:74011106-74011300 | GM12878 | blood: | n/a | n/a |
47 | EBF1 | chr2:74016210-74016437 | GM12878 | blood: | n/a | n/a |
48 | EBF1 | chr2:74035584-74035849 | GM12878 | blood: | n/a | n/a |
49 | EBF1 | chr2:74011089-74011368 | GM12878 | blood: | n/a | n/a |
50 | EBF1 | chr2:74021107-74021334 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:74010396-74010446 | HL-60 | blood: | n/a |
2 | chr2:74010396-74010446 | A549 | lung: | n/a |
3 | chr2:74010621-74010671 | H1-hESC | embryonic stem cell: | embryo |
4 | chr2:74010396-74010446 | PANC-1 | pancreas: | n/a |
5 | chr2:74010396-74010446 | HCF | heart: | n/a |
6 | chr2:74010396-74010446 | SAEC | small airway: | n/a |
7 | chr2:74010554-74010604 | PFSK-1 | brain: | n/a |
8 | chr2:74010554-74010604 | ProgFib | skin: | n/a |
9 | chr2:74010621-74010671 | AG04450 | lung: | fetal |
10 | chr2:74010621-74010671 | GM12878 | blood: | n/a |
11 | chr2:74010396-74010446 | Caco-2 | colon: | n/a |
12 | chr2:74010396-74010446 | Hela-S3 | cervix: | n/a |
13 | chr2:74010621-74010671 | SK-N-SH | brain: | n/a |
14 | chr2:74010621-74010671 | HUVEC | blood vessel: | n/a |
15 | chr2:74010621-74010671 | HRE | kidney: | n/a |
16 | chr2:74010621-74010671 | SK-N-SH_RA | brain: | n/a |
17 | chr2:74010554-74010604 | HCM | heart: | n/a |
18 | chr2:74010621-74010671 | Jurkat | blood: | n/a |
19 | chr2:74010554-74010604 | T-47D | breast: | n/a |
20 | chr2:74010554-74010604 | LNCaP | prostate: | n/a |
21 | chr2:74010621-74010671 | Caco-2 | colon: | n/a |
22 | chr2:74010621-74010671 | IMR90 | lung: | fetal |
23 | chr2:74010396-74010446 | HEEpiC | esophagus: | n/a |
24 | chr2:74010554-74010604 | U87 | brain: | n/a |
25 | chr2:74010554-74010604 | NB4 | blood: | n/a |
26 | chr2:74010621-74010671 | RPTEC | kidney: | n/a |
27 | chr2:74010554-74010604 | Jurkat | blood: | n/a |
28 | chr2:74010554-74010604 | PANC-1 | pancreas: | n/a |
29 | chr2:74010396-74010446 | SK-N-SH | brain: | n/a |
30 | chr2:74010621-74010671 | PrEC | prostate: | n/a |
31 | chr2:74010396-74010446 | SK-N-SH_RA | brain: | n/a |
32 | chr2:74010554-74010604 | HEK293 | kidney: | embryo |
33 | chr2:74010396-74010446 | SK-N-MC | brain: | n/a |
34 | chr2:74010396-74010446 | NT2-D1 | testis: | n/a |
35 | chr2:74010554-74010604 | SKMC | muscle: | n/a |
36 | chr2:74010554-74010604 | AG04450 | lung: | fetal |
37 | chr2:74010621-74010671 | U87 | brain: | n/a |
38 | chr2:74010621-74010671 | GM19239 | blood: | n/a |
39 | chr2:74010621-74010671 | HMEC | breast: | n/a |
40 | chr2:74010396-74010446 | HMEC | breast: | n/a |
41 | chr2:74010621-74010671 | AG10803 | skin: | n/a |
42 | chr2:74010396-74010446 | Hepatocyte | liver: | n/a |
43 | chr2:74010554-74010604 | GM06990 | blood: | n/a |
44 | chr2:74010554-74010604 | MCF10A-Er-Src | breast: | n/a |
45 | chr2:74010396-74010446 | GM12891 | blood: | n/a |
46 | chr2:74010554-74010604 | GM19239 | blood: | n/a |
47 | chr2:74010621-74010671 | Hepatocyte | liver: | n/a |
48 | chr2:74010554-74010604 | SK-N-MC | brain: | n/a |
49 | chr2:74010554-74010604 | MCF-7 | breast: | n/a |
50 | chr2:74010554-74010604 | Caco-2 | colon: | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-STAMBP-3 | chr2:74028839-74029096 | expReg_chr2_5950_+ |
No data |
No data |
Variant related genes | Relation type |
---|---|
DUSP11 | TF binding region |
C2orf78 | TF binding region |
DUSP11 | CpG island |
C2orf78 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190050800 | chr2:74010359-74010360 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs540754309 | chr2:74010387-74010388 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs577101243 | chr2:74010397-74010398 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs148898923 | chr2:74010405-74010406 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs529697192 | chr2:74010415-74010416 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs112200759 | chr2:74010438-74010439 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs148024891 | chr2:74010443-74010444 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs531239080 | chr2:74010451-74010452 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs142571969 | chr2:74010461-74010462 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs182362110 | chr2:74010519-74010520 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs185936003 | chr2:74010522-74010523 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs546822512 | chr2:74010533-74010534 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs568441448 | chr2:74010544-74010545 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs535435192 | chr2:74010555-74010556 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs190705912 | chr2:74010566-74010567 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs114036610 | chr2:74010577-74010578 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs536971908 | chr2:74010579-74010580 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs79364027 | chr2:74010587-74010588 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs13006598 | chr2:74010592-74010593 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs540715277 | chr2:74010593-74010594 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs12466586 | chr2:74010595-74010596 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs559876239 | chr2:74010601-74010602 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs188746972 | chr2:74010609-74010610 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs541419538 | chr2:74010613-74010614 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs563308654 | chr2:74010622-74010623 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs575989395 | chr2:74010628-74010629 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs558961722 | chr2:74010629-74010630 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs564662875 | chr2:74010669-74010670 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs192140542 | chr2:74010675-74010676 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs527488506 | chr2:74010676-74010677 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs561999993 | chr2:74010682-74010683 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs182726054 | chr2:74010700-74010701 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs375452763 | chr2:74010710-74010711 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs550673782 | chr2:74010715-74010716 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs568937325 | chr2:74010726-74010727 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs536930698 | chr2:74010730-74010731 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs552093872 | chr2:74010735-74010736 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs187093233 | chr2:74010760-74010761 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs534461606 | chr2:74010765-74010766 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs553139028 | chr2:74010774-74010775 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs191542642 | chr2:74010779-74010780 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs535557424 | chr2:74010783-74010784 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs184686551 | chr2:74010795-74010796 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs575353261 | chr2:74010821-74010822 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs545777879 | chr2:74010824-74010825 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs189568729 | chr2:74010826-74010827 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs573588498 | chr2:74010828-74010829 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs113695557 | chr2:74010831-74010832 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs113794361 | chr2:74010834-74010835 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs368331523 | chr2:74010838-74010839 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Developmental delay | 21147756 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:74007400-74010400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr2:74010000-74010400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr2:74010000-74010600 | Enhancers | NHEK | skin |
4 | chr2:74010000-74010800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr2:74010000-74010800 | Enhancers | Hela-S3 | cervix |
6 | chr2:74010000-74011000 | Enhancers | HMEC | breast |
7 | chr2:74010200-74010400 | Enhancers | A549 | lung |
8 | chr2:74010200-74010400 | Flanking Bivalent TSS/Enh | HepG2 | liver |
9 | chr2:74010200-74010600 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
10 | chr2:74010200-74010800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr2:74010400-74010600 | Flanking Active TSS | A549 | lung |
12 | chr2:74010400-74010600 | Bivalent/Poised TSS | HepG2 | liver |
13 | chr2:74010400-74010800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr2:74010600-74011000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
15 | chr2:74010600-74011000 | Active TSS | A549 | lung |
16 | chr2:74010600-74011000 | Active TSS | HepG2 | liver |
17 | chr2:74035000-74035200 | Enhancers | GM12878-XiMat | blood |